TY - JOUR T1 - Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT JO - Health Technology Assessment UR - https://eprints.whiterose.ac.uk/165392/ PY - 2021/06/16 AU - Hykin P AU - Prevost AT AU - Sivaprasad S AU - Vasconcelos JC AU - Murphy C AU - Kelly J AU - Ramu J AU - Alshreef A AU - Flight L AU - Pennington R AU - Hounsome B et al ED - DO - DOI: 10.3310/hta25380 PB - NIHR Journals Library VL - 25 IS - 83 Y2 - 2024/12/22 ER -